Jennifer LaFleur was ProPublica's director of computer-assisted reporting (CAR). She was also the CAR editor starting in 2003 for The Dallas Morning News, where she worked on the investigative team. She has directed CAR at the San Jose Mercury News and the St. Louis Post-Dispatch and was IREâs first training director. She has won awards for her coverage of disability, legal and open government issues. Ms. LaFleur is the co-author of IREâs Mapping for Stories: A Computer-Assisted Reporting Guide.
Jennifer LaFleur
Director of Computer Assisted Reporting
Medicare’s Failure to Track Doctors Wastes Billions on Name-Brand Drugs
The failure to track doctors who shun cheaper generics racks up huge costs for taxpayers in Medicare Part D, which fills one of every four U.S. prescriptions.
A Rap Sheet For Medicare’s Prescription Drug Program
An update on the new events since we published our Prescriber Checkup investigation.
Senator Asks States If They Alert Medicare to Problem Physicians
Citing a ProPublica investigation, Iowa Republican Charles Grassley said that if Medicaid and Medicare don’t share information on bad doctors, patients could be at risk.
Top Medicare Official: ‘We Can and Should Do More' to Oversee Drug Plan
Under pressure, Medicare's director tells a Senate panel the agency will intensify the search for abusive prescribing patterns and undertake other reforms.
Top Medicare Prescribers Rake In Speaking Fees From Drugmakers
Pay-to-prescribe is illegal, but doctors say they haven’t been influenced by the money they get for promoting drugs they also prescribe to large numbers of their patients.
Not Authorized to Prescribe Drugs? Medicare Pays Anyway.
Massage therapists, athletic trainers, interpretersand others who aren’t allowed to write prescriptions apparently issued at least417,000 under Medicare.
Inspector General Faults Medicare for Not Tracking 'Extreme' Prescribers
Echoing a ProPublica investigation, a report finds hundreds of doctors with questionable and potentially dangerous prescribing patterns. In a response, Medicare says it will step up monitoring and review the list for fraud or abuse.
Eight Ways to Strengthen Medicare’s Drug Benefit
Former government officials, analysts and researchers say Medicare could improve oversight of its Part D drug benefit with these steps.
How We Analyzed Medicare’s Drug Data
ProPublica obtained Medicare Part D data from the Centers for Medicare and Medicaid Services (CMS) under the Freedom of Information Act. Here follows more information about the data and how we analyzed it.
Prescriber Checkup
Medicare’s popular prescription-drug program serves more than 42 million people and pays for more than one of every four prescriptions written nationwide. Use this tool to find and compare doctors and other providers in Part D in 2015.
Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
Prescription data obtained by ProPublica shows wide use of antipsychotics, narcotics and other drugs dangerous for older adults, but Medicare officials say it's not their job to look for unsafe prescribing or weed out doctors with troubled backgrounds.
Has Obama Kept His Open-Government Pledge?
In his first term, President Obama promised that government would “do business in the light of day,” but skeptics say the record is mixed.
At Some Schools, Achievement Lags Behind Opportunity
Data show that, in some states, Advanced Placement exam passing rates remain lower in schools with more poor students.
Find Voting Rights Violations in Nursing Homes
Not all long-term care residents get to exercise their right to vote. Dozens of nursing homes have violated residents’ voting rights. Find out more using our Nursing Home Inspect database.
Updated: Dialysis Facility Tracker
ProPublica obtained data about the performance of more than 5,000 U.S. dialysis clinics. Our Dialysis Facility Tracker allows patients to compare clinics on such measures as patient survival, infection control, hospitalization rates and transplant rates.
Updated Recovery Tracker
Once again, we’ve taken all the data used on the government’s stimulus Web site, Recovery.gov, spiffed it up and added thousands of other recovery spending records — the law doesn't require all recipients to report to Recovery.gov.
